InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Roemer Alan S., 董事. Director active across 2 companies, notably NexImmune, Inc.. In total, 7 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €49k. Activity tracked since 16 August 2022. The latest transaction was disclosed on 22 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Roemer Alan S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
36,232 股@ US$1.3839.3% 占其流量Common StockSEC:0001643070-25-000005:0
102,459 股@ US$0.184425.3% 占其流量Common StockSEC:0001415889-25-012287:0
126,582 股Common StockSEC:0001415889-24-024868:0
102,459 股Common StockSEC:0001209191-23-058719:0
3,833 股@ €1.975312.3% 占其流量Common StockSEC:0001209191-23-056514:0
26,315 股@ US$1.9074.7% 占其流量Common StockSEC:0001209191-22-046600:0
标准退出：2022年11月14日 (T+90)
12,634 股@ €2.145950.0% 占其流量Common StockSEC:0001209191-21-070944:0
7 条申报中的 7 条
About Roemer Alan S.
Roemer Alan S. is a Administrateur at IN8BIO, INC. and NexImmune, Inc. He has 7 filings in total. Across the 7 sampled recent filings, the known transactions span from 2021-12-22 to 2025-12-23, with EUR 49160 of buys and EUR 0 of sells, and the most frequent transaction nature is Attribution.
